Application of magnetic field hyperthermia and superparamagnetic iron oxide nanoparticles to HIV-1-specific T-cell cytotoxicity
Open Access
- 1 July 2013
- journal article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. 8, 2543-54
Abstract
Peer reviewed article authored by (Williams JP, Southern P, Lissina A, Christian HC, Sewell AK, Phillips R, Pankhurst Q, Frater J). Read article or submit your manuscript for publishing.Keywords
This publication has 55 references indexed in Scilit:
- HIV rebounds from latently infected cells, rather than from continuing low-level replicationProceedings of the National Academy of Sciences, 2008
- Genetic Characterization of Rebounding Human Immunodeficiency Virus Type 1 in Plasma during Multiple Interruptions of Highly Active Antiretroviral TherapyJournal of Virology, 2003
- Origin of Human Immunodeficiency Virus Type 1 Quasispecies Emerging after Antiretroviral Treatment Interruption in Patients with Therapeutic FailureJournal of Virology, 2002
- Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapyJournal of Clinical Investigation, 2000
- HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppressionProceedings of the National Academy of Sciences, 1999
- Rate of HIV-1 RNA rebound upon stopping antiretroviral therapyAIDS, 1999
- Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapyProceedings of the National Academy of Sciences, 1997
- Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma ViremiaScience, 1997
- Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral TherapyScience, 1997
- In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latencyNature Medicine, 1995